Sunday 8 December 2019
Home      All news      Contact us      India
business-standard - 4 days ago

US launch of second oncology biosimilar to boost Biocon s earnings

Even as the Street will monitor product ramp-up, commercialisation of more biosimilars will drive prospects further


Latest News
Hashtags:   

launch

 | 

second

 | 

oncology

 | 

biosimilar

 | 

boost

 | 

Biocon

 | 

earnings

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources